Mydecine Innovations Pink Sheet Forecast - Naive Prediction
| MYCOF Stock | USD 0.13 0.00 0.00% |
Mydecine Pink Sheet outlook is based on your current time horizon. We recommend always using this module together with an analysis of Mydecine Innovations' historical fundamentals, such as revenue growth or operating cash flow patterns.
As of 28th of January 2026, the relative strength index (RSI) of Mydecine Innovations' share price is approaching 37. This indicates that the pink sheet is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Mydecine Innovations, making its price go up or down. Momentum 37
Sell Extended
Oversold | Overbought |
Using Mydecine Innovations hype-based prediction, you can estimate the value of Mydecine Innovations Group from the perspective of Mydecine Innovations response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Mydecine Innovations Group on the next trading day is expected to be 0.14 with a mean absolute deviation of 0.03 and the sum of the absolute errors of 1.60. Mydecine Innovations after-hype prediction price | USD 0.13 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Mydecine |
Mydecine Innovations Additional Predictive Modules
Most predictive techniques to examine Mydecine price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mydecine using various technical indicators. When you analyze Mydecine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Mydecine Innovations Naive Prediction Price Forecast For the 29th of January
Given 90 days horizon, the Naive Prediction forecasted value of Mydecine Innovations Group on the next trading day is expected to be 0.14 with a mean absolute deviation of 0.03, mean absolute percentage error of 0, and the sum of the absolute errors of 1.60.Please note that although there have been many attempts to predict Mydecine Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Mydecine Innovations' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Mydecine Innovations Pink Sheet Forecast Pattern
| Backtest Mydecine Innovations | Mydecine Innovations Price Prediction | Buy or Sell Advice |
Mydecine Innovations Forecasted Value
In the context of forecasting Mydecine Innovations' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Mydecine Innovations' downside and upside margins for the forecasting period are 0 and 19.43, respectively. We have considered Mydecine Innovations' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Mydecine Innovations pink sheet data series using in forecasting. Note that when a statistical model is used to represent Mydecine Innovations pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.2642 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0263 |
| MAPE | Mean absolute percentage error | 0.2058 |
| SAE | Sum of the absolute errors | 1.6015 |
Predictive Modules for Mydecine Innovations
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Mydecine Innovations. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Mydecine Innovations After-Hype Price Density Analysis
As far as predicting the price of Mydecine Innovations at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mydecine Innovations or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Mydecine Innovations, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Mydecine Innovations Estimiated After-Hype Price Volatility
In the context of predicting Mydecine Innovations' pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mydecine Innovations' historical news coverage. Mydecine Innovations' after-hype downside and upside margins for the prediction period are 0.01 and 19.42, respectively. We have considered Mydecine Innovations' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Mydecine Innovations is out of control at this time. Analysis and calculation of next after-hype price of Mydecine Innovations is based on 3 months time horizon.
Mydecine Innovations Pink Sheet Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Mydecine Innovations is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mydecine Innovations backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mydecine Innovations, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 19.29 | 0.00 | 0.01 | 0 Events / Month | 2 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.13 | 0.13 | 0.00 |
|
Mydecine Innovations Hype Timeline
Mydecine Innovations is now traded for 0.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Mydecine is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is now at 0.47%. %. The volatility of related hype on Mydecine Innovations is about 137785.71%, with the expected price after the next announcement by competition of 0.14. The company recorded a loss per share of 4.68. Mydecine Innovations last dividend was issued on the 1st of April 2019. The entity had 1:45 split on the 1st of April 2019. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out Historical Fundamental Analysis of Mydecine Innovations to cross-verify your projections.Mydecine Innovations Related Hype Analysis
Having access to credible news sources related to Mydecine Innovations' direct competition is more important than ever and may enhance your ability to predict Mydecine Innovations' future price movements. Getting to know how Mydecine Innovations' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mydecine Innovations may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CHHE | China Health Industries | 0.12 | 2 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TELIF | Telescope Innovations Corp | 0.00 | 0 per month | 5.34 | 0.05 | 13.04 | (10.53) | 69.65 | |
| LUFFF | Luff Enterprises | 0.00 | 0 per month | 0.00 | 0.17 | 60.00 | 0.00 | 1,899 | |
| OASMY | Oasmia Pharmaceutical AB | 0.01 | 6 per month | 0.00 | (0.18) | 0.00 | 0.00 | 50.00 | |
| BTCY | Biotricity | (0.01) | 3 per month | 0.00 | (0.11) | 12.07 | (10.00) | 32.11 | |
| QPTFF | Quest PharmaTech | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PTKFY | Kalbe Farma Tbk | 0.00 | 0 per month | 2.60 | (0.01) | 6.22 | (8.31) | 25.33 | |
| GLABF | Gemina Laboratories | 0.00 | 0 per month | 0.00 | (0.04) | 0.00 | (27.54) | 144.07 | |
| VPHIF | Valeo Pharma | 0.01 | 7 per month | 0.00 | (0.13) | 0.00 | 0.00 | 66.67 | |
| BQST | BioQuest Corp | 0.01 | 14 per month | 0.00 | (0.14) | 0.00 | 0.00 | 49.00 |
Other Forecasting Options for Mydecine Innovations
For every potential investor in Mydecine, whether a beginner or expert, Mydecine Innovations' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Mydecine Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Mydecine. Basic forecasting techniques help filter out the noise by identifying Mydecine Innovations' price trends.Mydecine Innovations Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Mydecine Innovations pink sheet to make a market-neutral strategy. Peer analysis of Mydecine Innovations could also be used in its relative valuation, which is a method of valuing Mydecine Innovations by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Mydecine Innovations Market Strength Events
Market strength indicators help investors to evaluate how Mydecine Innovations pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Mydecine Innovations shares will generate the highest return on investment. By undertsting and applying Mydecine Innovations pink sheet market strength indicators, traders can identify Mydecine Innovations Group entry and exit signals to maximize returns.
Mydecine Innovations Risk Indicators
The analysis of Mydecine Innovations' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Mydecine Innovations' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting mydecine pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 6.88 | |||
| Standard Deviation | 21.18 | |||
| Variance | 448.57 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Mydecine Innovations
The number of cover stories for Mydecine Innovations depends on current market conditions and Mydecine Innovations' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mydecine Innovations is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mydecine Innovations' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Mydecine Pink Sheet
Mydecine Innovations financial ratios help investors to determine whether Mydecine Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mydecine with respect to the benefits of owning Mydecine Innovations security.